View in EDS HTML Full Text PDF Full Text

Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.

Saved in:
Bibliographic Details
Title: Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
Authors: Overgaard RV; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark., Ingwersen SH; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark., Tornøe CW; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.
Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2015 Oct; Vol. 4 (10), pp. 565-75. Date of Electronic Publication: 2015 Sep 22.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2163-8306 (Print) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26535157
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Overgaard+RV%22">Overgaard RV</searchLink>; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Ingwersen+SH%22">Ingwersen SH</searchLink>; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Tornøe+CW%22">Tornøe CW</searchLink>; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580011%22">CPT: pharmacometrics & systems pharmacology</searchLink> [CPT Pharmacometrics Syst Pharmacol] 2015 Oct; Vol. 4 (10), pp. 565-75. <i>Date of Electronic Publication: </i>2015 Sep 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101580011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2163-8306 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221638306%22">21638306 </searchLink><i>NLM ISO Abbreviation: </i>CPT Pharmacometrics Syst Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26535157
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/psp4.12015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 565
    Titles:
      – TitleFull: Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Overgaard RV
      – PersonEntity:
          Name:
            NameFull: Ingwersen SH
      – PersonEntity:
          Name:
            NameFull: Tornøe CW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2015 Oct
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-print
              Value: 2163-8306
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: CPT: pharmacometrics & systems pharmacology
              Type: main
ResultId 1